Focusing on IL-6/STAT3 Pathway shows the approach of anti-IL-6 antibody (tocilizumab) in the treatment of multiple hydrocephalus. Current Opinion [Internet]. 2021 Dec. 10 [cited 2025 Jan. 23];1(01):15-9. Available from: https://currentopinion.info/index.php/co/article/view/14